Ndx Pharma Labs Private Limited - Company Profile

It is a food and beverages private limited company based in Mangalagiri, Andhra Pradesh, India, established in 2018.
2018 Mangalagiri, Andhra Pradesh, India Active
Last Updated:
About Ndx Pharma Labs Private Limited

Ndx Pharma Labs Private Limited, a active private limited company, was established on 20 April 2018 in Mangalagiri, Andhra Pradesh, India. Engaging in artificial fibres within the food and beverages sector, it holds CIN: U24304AP2018PTC108231. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Venkatanaga Rajyalakshmi Mynampati (Director), Venkata Ramana Manikumar Mynampati (Managing Director). Its latest AGM occurred on 16 December 2020, with the balance sheet filed on 31 March 2020. It is based at D. No: 4-1 Kaza, Mangalagiri, Andhra Pradesh, 522503.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304AP2018PTC108231

  • Registration Number

    108231

  • Incorporation Date

    20 April 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 9 Months
  • Last Filing with ROC 31 Mar 2020
  • Revenue Growth **** %
  • Profit Growth **** -5.03%
  • Ebitda **** -12.13%
  • Net Worth -21.62%
  • Total Assets -7.70%
Company report

Ndx Pharma Labs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ndx Pharma Labs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Ndx Pharma Labs Private Limited?
Current Directors
Name Designation Appointment Date Status
Venkatanaga Rajyalakshmi Mynampati Director 20 Apr 2018 Current
Venkata Ramana Manikumar Mynampati Managing Director 20 Apr 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ndx Pharma Labs.

Ndx Pharma Labs Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 5.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.62%.

Ndx Pharma Labs revenue growth over time
Ndx Pharma Labs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
-7.70%
*******
*******
*******
*******
Profit or Loss
*******
-5.03%
*******
*******
*******
*******
Net Worth
*******
-21.62%
*******
*******
*******
*******
EBITDA
*******
-12.13%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ndx Pharma Labs?

Unlock access to Ndx Pharma Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ndx Pharma Labs?

Unlock and access historical data on people associated with Ndx Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ndx Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ndx Pharma Labs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ndx Pharma Labs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Ndx Pharma Labs Private Limited last Annual general meeting of members was held on 16 Dec 2020 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Ndx Pharma Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Vijayawada. was documented.

  • Director Appointment

    Venkatanaga Rajyalakshmi Mynampati was appointed as a Director was appointed as a Director on 20 Apr 2018 & has been associated with this company since 7 years 9 months . was recorded as a recent event.

  • Director Appointment

    The activity Venkata Ramana Manikumar Mynampati was appointed as a Managing Director was appointed as a Managing Director on 20 Apr 2018 & has been associated with this company since 7 years 9 months . was completed.

  • Company Incorporation

    The activity Ndx Pharma Labs Private Limited was registered on 20 Apr 2018 with Roc Vijayawada & aged 7 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ndx Pharma Labs Private Limited?

The CIN of Ndx Pharma Labs Private Limited is U24304AP2018PTC108231.

Where is Ndx Pharma Labs Private Limited headquartered?

Ndx Pharma Labs Private Limited is headquartered at D. No: 4-1 Kaza, Mangalagiri, Andhra Pradesh, 522503.

When was Ndx Pharma Labs Private Limited incorporated?

Ndx Pharma Labs Private Limited was incorporated on 20 April 2018.

Who are the current directors of Ndx Pharma Labs Private Limited?

The current directors of Ndx Pharma Labs Private Limited are

What is the primary industry of Ndx Pharma Labs Private Limited?

The primary industry of Ndx Pharma Labs Private Limited is Food And Beverages.

Is Ndx Pharma Labs Private Limited a listed company?

Ndx Pharma Labs Private Limited is unlisted.

What is the capital structure of Ndx Pharma Labs Private Limited?

The authorized capital of Ndx Pharma Labs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available